JAZZ Sale Disclosure
Cozadd Bruce C · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$1.3M
Cozadd Bruce C Director
JAZZ
Jazz Pharmaceuticals
JAZZ
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
JAZZ daily price context
Close on/before transaction
$214.44
Nov 2, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 6,000 shares @ $215.84
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193210-26-000030
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$1.3M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Jazz Pharmaceuticals Plc JAZZ Current | Sale | Nov 2, 2026 | $1.3M |